Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Xerostomia 2Head and Neck Neoplasms 2Salivary Gland Neoplasms 1Radiation Injuries 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mucositis 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Cetuximab 11Cisplatin 10Radiotherapy 8Docetaxel 8Erlotinib Hydrochloride 7Paclitaxel 6Gemcitabine 6Chemotherapy, Adjuvant 6Immunohistochemistry 5Sorafenib 4Radiosurgery 4Carboplatin 4Capecitabine 4Biopsy 4sargramostim 3Vorinostat 3Trastuzumab 3Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Nivolumab 3N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 3Lapatinib 3Irinotecan 3Filgrastim 3Doxorubicin 3Bevacizumab 3ixabepilone 2aldesleukin 2Taxes 2SS1(dsFv)PE38 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Salivary Gland Neoplasms × Oral Hygiene × Clear all
NCT02589938 2026-02-27

ACUPUNCTURE

Wake Forest University Health Sciences

Phase NA Completed
258 enrolled 16 charts
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡